Mehryar Habibi Roudkenar

Mehryar Habibi Roudkenar

Auto-generated profile, based on publicly available information

Mehryar Habibi Roudkenar

Burn and Regenerative Medicine Research Center, School of Medicine, Velayat Hospital, Guilan University of Medical Sciences, Rasht, Iran

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
MRMehryar Habibi Roudkenar
Mehryar Habibi Roudkenar
YKYoshikazu Kuwahara
Yoshikazu Kuwahara
TBTaisuke Baba
Taisuke Baba
ARAmaneh Mohammadi Roushandeh
Amaneh Mohammadi Roushandeh
SEShigeko Ebishima
Shigeko Ebishima
MFManabu Fukumoto
Manabu Fukumoto
Lipocalin 2 (Lcn2, NGAL) is a member of the lipocalin superfamily with diverse functions such as the transport of fatty acids and the induction of ap

1 September 2012 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
MMMohammad Mohammadzadeh
Mohammad Mohammadzadeh
RHRaheleh Halabian
Raheleh Halabian
AGAhmad Gharehbaghian
Ahmad Gharehbaghian
NANaser Amirizadeh
Naser Amirizadeh
ANAli Jahanian Najafabadi
Ali Jahanian Najafabadi
MRMehryar Habibi Roudkenar
Mehryar Habibi Roudkenar
The most prominent capabilities of mesenchymal stem cells (MCSs) which make them promising for therapeutic applications are their capacity to endure and implant in the target tissue. However, the therapeutic applications of these cells are limited due to their early death within the first few days following transplantation. Therefore, to improve cell therapy efficacy, it is necessary to manipulate MSCs to resist severe stresses imposed by microenvironment. In this study, we manipulated MSCs to express a cytoprotective factor, nuclear factor erythroid-2 related factor 2 (Nrf2) to address this issue. Full-length human Nrf2 cDNA was isolated and TOPO cloned into TOPO cloning vector and then transferred to gateway adapted adenovirus expression vector by LR recombination reaction. Afterwards, the Nrf2 bearing recombinant virus was prepared in appropriate mammalian cell line and used to infect MSCs. The viability and apoptosis of the Nrf2 expressing MSCs were evaluated following hypoxic and oxidative stress conditions. Transient expression of Nrf2 by MSCs protected them against cell death and the apoptosis triggered by hypoxic and oxidative stress conditions. Nrf2 also enhanced the activity of SOD and HO-1. These findings could be used as a strategy for prevention of graft cell death in MSC-based cell therapy. It also indicates that management of cellular stress responses can be used for practical applications.

1 December 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
YTYuko Takashi
Yuko Takashi
KTKazuo Tomita
Kazuo Tomita
YKYoshikazu Kuwahara
Yoshikazu Kuwahara
MRMehryar Habibi Roudkenar
Mehryar Habibi Roudkenar
ARAmaneh Mohammadi Roushandeh
Amaneh Mohammadi Roushandeh
TSTomoaki Sato
Tomoaki Sato

1 December 2015 in Redox Biology
Verified
Journal Article
Open access
ASAhmad Salimi
Ahmad Salimi
MRMehryar Habibi Roudkenar
Mehryar Habibi Roudkenar
LSLeila Sadeghi
Leila Sadeghi
AMAlireza Mohseni
Alireza Mohseni
ESEnayatollah Seydi
Enayatollah Seydi
JPJalal Pourahmad
Jalal Pourahmad
To investigate the effects ofellagic acid (EA) on the cytotoxicity, B-lymphocytes isolated from CLL patients and healthy individuals. Flow cytometric assay was used to measure the percentage of apoptosis versus necrosis, intracellular active oxygen radicals (ROS), mitochondrial membrane potential (MMP) and the caspase-3 activity and then mitochondria were isolated from both groups B-lymphocytes and parameters of mitochondrial toxicity was investigated. Based on our results EA decreased the percentage of viable cells and induced apoptosis. EA increased ROS formation, mitochondria swelling, MMP decrease and cytochrome c release in mitochondria isolated from CLL BUT NOT healthy B-lymphocytes while pre-treatment with cyclosporine A and Butylated hydroxyl toluene (BHT) prevented these effects. Our results suggest that EA can act as an anti cancer candidate by directly and selectively targeting mitochondria could induce apoptosis through mitochondria pathway with increasing ROS production which finally ends in cytochrome c release, caspase 3 activation and apoptosis in cancerous B-lymphocytes isolated from CLL patients.

1 August 2020 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
HJHanieh Jabbari
Hanieh Jabbari
ARAmaneh Mohammadi Roushandeh
Amaneh Mohammadi Roushandeh
MRMojdeh Kheirandish Rostami
Mojdeh Kheirandish Rostami
MRMohammad Taghi Razavi-Toosi
Mohammad Taghi Razavi-Toosi
MSMohammad Ali Shokrgozar
Mohammad Ali Shokrgozar
MRMehryar Habibi Roudkenar
Mehryar Habibi Roudkenar

1 December 2020 in Brain Research Bulletin
Verified
Journal Article
Closed access
ZPZahra Pourmohammadi-Bejarpasi
Zahra Pourmohammadi-Bejarpasi
ARAmaneh Mohammadi Roushandeh
Amaneh Mohammadi Roushandeh
ASAlia Saberi
Alia Saberi
MRMojdeh Kheirandish Rostami
Mojdeh Kheirandish Rostami
STSeyyed Mohammadtaghi Razavi Toosi
Seyyed Mohammadtaghi Razavi Toosi
MRMehryar Habibi Roudkenar
Mehryar Habibi Roudkenar